{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Cryo-Cell International, Inc.
Is Cryo-Cell International, Inc. overvalued or undervalued?
As of October 18, 2022, Cryo-Cell International, Inc. is considered overvalued and has a risky financial outlook due to its negative P/E ratio, high EV to EBITDA ratio, and poor stock performance compared to peers and the S&P 500.
Is Cryo-Cell International, Inc. technically bullish or bearish?
As of June 13, 2025, Cryo-Cell International, Inc. shows a bearish trend with moderate strength, supported by bearish indicators across multiple time frames, despite some mixed signals from the MACD.
What does Cryo-Cell International, Inc. do?
Cryo-Cell International, Inc. is a micro-cap company in the transport services industry, with recent net sales of $8 million and a market cap of $70.88 million. It is currently loss-making, with a P/E ratio of NA and a dividend yield of 0.00%.
How big is Cryo-Cell International, Inc.?
As of Jun 18, Cryo-Cell International, Inc. has a market capitalization of 70.88 million, with recent net sales of 32.10 million and a net profit of 0.13 million over the last four quarters. The company's shareholder's funds are -13.22 million, and total assets are 64.68 million as of Nov'24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
